ArticleSeminars in arthritis and rheumatism2024
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation.
Open access · bronzeAbstract read
In one paragraph
Article in Seminars in arthritis and rheumatism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 7 citations in OpenAlex.
- From immune activation to symptom burden: mechanisms and translational implications of immune-symptom uncoupling in Sjögren's disease.Frontiers in immunology · 2026Review
- Non-Conventional and Emerging Autoantibodies in Sjögren's Disease.Journal of inflammation research · 2026Review
- Clinical Implications of Antinuclear Antibody (ANA) and Anti-Ro/Anti-La Antibody Profile in Patients with Primary Sjögren's Syndrome: A Multicenter Cross-Sectional Study of a National Egyptian Cohort.Open access rheumatology : research and reviews · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
50 authors at 20 institutions in 15 countries.
Rachael A GordonDepartment of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, USA.
Yann NguyenDepartment of Rheumatology, National Reference Center for Auto-immune Diseases, Sjogren's ERN Reconnect Center, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Université Paris-Saclay, INSERM U1184, Le Kremlin Bicêtre, Paris, France.
Nathan FoulquierLBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France.
Maxime BeydonDepartment of Rheumatology, National Reference Center for Auto-immune Diseases, Sjogren's ERN Reconnect Center, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Université Paris-Saclay, INSERM U1184, Le Kremlin Bicêtre, Paris, France.
Tamer A GheitaRheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Raouf HajjiInternal Medicine Department, Sidi Bouzid Hospital, University of Sousse, Medicine Faculty of Sousse, 4000, Sousse, Tunisia; International Medical Community (IMC), Via Nomentana, 403, Rome, Lazio 00162, Italy.
Ilfita SahbudinRheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK.
Alberta HoiMonash University, Victoria, Australia.
Wan-Fai NgTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust & Newcastle University, Newcastle upon Tyne, UK.
Jose Alexandre MendonçaPostgraduate Program in Health Sciences/Rheumatology/Ultrasonography Service, Pontifical Catholic University of Campinas, SP, Brazil.
Daniel J WallaceCedars-Sinai Medical Center, Los Angeles, California, USA; University of California, David Geffen School of Medicine, Los Angeles, California, USA.
Beverley SheaOttawa Hospital Research Institute, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
George Aw BruynDepartment of Rheumatology, Tergooi MC hospitals, Hilversum, the Netherlands.
Susan M GoodmanDivision of Rheumatology, Hospital for Special Surgery, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Benjamin A FisherRheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK.
Chiara BaldiniRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Karina D TorralbaDivision of Rheumatology, Department of Medicine, Loma Linda University School of Medicine, Loma Linda, California, USA; Division of Rheumatology, Department of Medicine, University of California Riverside School of Medicine, Riverside, California, USA.
Hendrika BootsmaDepartment Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Esen K AkpekOcular Surface Disease Clinic, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sezen KarakusOcular Surface Disease Clinic, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Alan N BaerDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Soumya D ChakravartyJanssen Scientific Affairs, LLC, Horsham, PA, USA, Drexel University College of Medicine, Philadelphia, PA, USA.
Lene TerslevCenter for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, The University of Copenhagen, Copenhagen, Denmark.
Maria-Antonietta D'AgostinoRheumatology Department, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, IRCSS, Rome, Italy.
Xavier MarietteDepartment of Rheumatology, National Reference Center for Auto-immune Diseases, Sjogren's ERN Reconnect Center, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Université Paris-Saclay, INSERM U1184, Le Kremlin Bicêtre, Paris, France.
Dana DiRenzoRheumatology Department, University of Pennsylvania, Philadelphia, PA, USA.
Astrid RasmussenGenes and Human Disease Program, Oklahoma Medical Research Foundation. Oklahoma City, OK, USA.
Athena PapasTufts School of Dental Medicine Boston, Massachusetts, USA.
Cristina MontoyaRegistered Dietitian Active patient volunteer for the Sjogren's Society of Canada, Canada.
Suzanne ArendsDepartment Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Md Yuzaiful Md YusofLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, UK; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK.
Ionut PintilieRheumatology Department, Connect Medical, Piatra Neamt, Romania.
Blake M WarnerSalivary Disorders Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Katherine M HammittSjögren's Foundation, Reston, VA, USA.
Vibeke StrandDivision of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA.
Coralie BouillotSjögren's Europe, Bienne, Switzerland.
Peter TugwellDept of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Nevsun InancDivision of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey.
José Luis AndreuRheumatology Department, University Hospital Puerta de Hierro, Majadahonda, Spain.
Marie Wahren-HerleniusDivision of Rheumatology, Department of Medicine, Karolinska Institute, Sweden; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Norway.
Valerie Devauchelle-PensecLBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France.
Caroline H ShiboskiDepartment of Orafacial Sciences, University of California San Francisco, San Francisco, CA, USA.
Anas BenyoussefOphthalmology Department, centre hospitalier universitaire de Brest, 2, avenue Foch, 29609 Brest cedex, France.
Sharmila MasliBoston University School of Medicine, Boston, MA, USA.
Adrian Y S LeeDepartment of Clinical Immunology & Allergy, Westmead Hospital, Westmead, NSW, Australia.
Divi CornecLBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France.
Simon BowmanRheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK; Institute of Inflammation & Ageing, University of Birmingham, Birmingham, UK, Rheumatology Department, University Hospitals Birmingham, Birmingham, UK and Rheumatology Department, Milton Keynes University Hospital, Milton Keynes, UK.
Maureen RischmuellerThe Queen Elizabeth Hospital, Woodville and University of Adelaide, Adelaide, Australia.
Sara S McCoyDepartment of Medicine, Division of Rheumatology, University of Wisconsin School of Medicine and Public Health, Madison, USA. Electronic address: ssmccoy@medicine.wisc.edu.
Raphaele SerorDepartment of Rheumatology, National Reference Center for Auto-immune Diseases, Sjogren's ERN Reconnect Center, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Université Paris-Saclay, INSERM U1184, Le Kremlin Bicêtre, Paris, France.
Inserm · FRJohns Hopkins University · USTufts University · USUniversity of California, San Francisco · USUniversity of Ottawa · CANational Institutes of Health · USStanford University · USUniversity Hospitals Birmingham NHS Foundation Trust · GBUniversity Medical Center Groningen · NLUniversity of Wisconsin–Madison · USCairo University · EGCedars-Sinai Medical Center · USHospital for Special Surgery · USJanssen (United States) · USKarolinska Institutet · SEMarmara University · TRMonash University · AUNewcastle upon Tyne Hospitals NHS Foundation Trust · GBQueen Elizabeth Hospital · AURome Foundation · US
Funding
Institutional Career Development CoreKL2TR002374 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI Bo Liu, Marin Leigh Schweizer · 2017 to 2026
$9.7MTargeting Endogenous Mesenchymal Stromal Cells with Ruxolitinib to Treat Sialadenitis in Sjogren's SyndromeR03DE031340 · NIDCR · UNIVERSITY OF WISCONSIN-MADISON · PI MCCOY, SARA · 2022 to 2023
$311kNCATS NIH HHS KL2 TR002374NIDCR NIH HHS R03 DE031340
Abstract
Sjögren's disease (SjD) is a systemic autoimmune exocrinopathy with key features of dryness, pain, and fatigue. SjD can affect any organ system with a variety of presentations across individuals. This heterogeneity is one of the major barriers for developing effective disease modifying treatments. Defining core disease domains comprising both specific clinical features and incorporating the patient experience is a critical first step to define this complex disease. The OMERACT SjD Working Group held its first international collaborative hybrid meeting in 2023, applying the OMERACT 2.2 filter toward identification of core domains. We accomplished our first goal, a scoping literature review that was presented at the Special Interest Group held in May 2023. Building on the domains identified in the scoping review, we uniquely deployed multidisciplinary experts as part of our collaborative team to generate a provisional domain list that captures SjD heterogeneity.
Indexed as
Sjogren's SyndromeFatigueHumansPainTreatment OutcomeArtificial intelligenceBIBOTOMERACTReviewScoping literature reviewSjogren's disease
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.